By reactivating a long-lost gene, researchers were able to lower uric acid levels and stop damaging fat accumulation in human ...

CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.

Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a ...

Ecuadorian scientists are developing a biotechnological strategy to stop banana wilt by genetically editing the causative ...

Gout is one of the oldest documented human illnesses. It develops when sharp crystals form inside joints, triggering intense swelling and pain, and is ...

Penn and CHOP researchers want to develop urea cycle disorder treatments using CRISPR gene-editing therapy. Get unlimited access to Inquirer.com and The Inquirer App, plus 5 articles each month to ...

Cacao yields in West Africa are collapsing by up to 40% due to drought and climate stress. These conditions have driven the steepest price increases for cacao in recorded history, destabilising the ...

A leading bioethicist at Hiroshima University is calling for an anticipatory, rather than reactive, approach to ethics after ...

ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions ('Dyadic'), a global biotechnology ...

The N-glycans attached to the Fc region of immunoglobulin G (IgG) contain combinations of core fucose, bisecting GlcNAc, galactose, and sialic acid; variations in these monosaccharides - regulated ...

CRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of +11.36% and -86.76%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the ...